Sign in
4

Changes in Ownership

agilon health, inc. Filed Acc 0001209191-23-021209

Chief Strategy & Dev. Officer sold 120,000 shares at an average $28.70 ($3,444,290)

  • Chief Strategy & Dev. Officer acquired 120,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Desai Veeral · Chief Strategy & Dev. Officer

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2023-03-23 Exercise or conversion : show line 1 in the form +22,710 $3.00 $68,130 299,439 D
2023-03-23 Sale : show line 2 in the form −22,710 $28.71 $651,911 276,729 D
2023-03-24 Exercise or conversion : show line 3 in the form +97,290 $3.00 $291,870 374,019 D
2023-03-24 Sale : show line 4 in the form −97,290 $28.70 $2,792,379 276,729 D
Open-market sales · 120,000 sh · avg $28.70 · $3,444,290

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2023-03-23 Exercise or conversion : show line 5 in the form Options (Rights to Buy) −22,710 1,617,290 D
2023-03-24 Exercise or conversion : show line 6 in the form Options (Rights to Buy) −97,290 1,520,000 D
Loading xslF345X04/doc4.xml…